Dr. Michael Horberg has responsibilities for Research, Medical Education, Community Health, Medicaid, Genetics, HIV and STD, Transgender Health, and Infection Prevention. He also is the executive director of the Mid-Atlantic Permanente Research Institute (MAPRI). As associate medical director, Dr. Horberg is responsible for all research activities in Kaiser Permanente Mid-Atlantic States, along with serving as the designated institutional official for medical education. He serves as the medical director for Kaiser Permanente Mid-Atlantic States Community Health and is the Medicaid leader for the medical group, including chief medical officer for Kaiser Permanente Mid-Atlantic States in Maryland Medicaid. Michael leads HIV, STD, infection prevention, and transgender health care efforts in the region, and HIV and STD care program-wide for Kaiser Permanente. Dr. Horberg leads our medical genetics and genomics strategy for the medical group and is the executive sponsor for Kaiser Permanente Mid-Atlantic States’ Commission on Cancer Accreditation and National Surgical Quality Improvement Program.
He has served on the Presidential (Obama) Advisory Council on HIV/AIDS. He is a Fellow of the American College of Physicians and the Infectious Disease Society of America (IDSA). He is past chair of the HIV Medicine Association of IDSA. He co-chairs the society’s HIV Primary Care Guideline Committee.
Dr. Horberg has published over 150 manuscripts in peer-reviewed literature or conferences. He attended Boston University Medical School and received his Master of Advanced Studies from Uthe university of California San Francisco.
Current role